Operating Lease, Right-of-Use Asset of Actinium Pharmaceuticals, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Actinium Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Actinium Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,215,000, a 34% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Actinium Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,215,000 -$623,000 -34% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $1,373,000 -$617,000 -31% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $1,530,000 -$610,000 -29% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $1,685,000 -$604,000 -26% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $1,838,000 -$598,000 -25% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $1,990,000 -$591,000 -23% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $2,140,000 -$404,000 -16% 31 Mar 2024 10-Q 26 Apr 2024 2024 Q1
Q4 2023 $2,289,000 -$52,000 -2.2% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $2,436,000 -$18,000 -0.73% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $2,581,000 -$48,000 -1.8% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $2,544,000 +$2,392,000 +1574% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $2,341,000 +$2,100,000 +871% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $2,454,000 +$2,126,000 +648% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $2,629,000 +$2,216,000 +537% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $152,000 -$344,000 -69% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $241,000 -$338,000 -58% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $328,000 -$331,000 -50% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $413,000 -$325,000 -44% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $496,000 -$319,000 -39% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $579,000 -$228,000 -28% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q3 2020 $659,000 -$304,434 -32% 30 Sep 2020 10-Q 23 Oct 2020 2020 Q3
Q2 2020 $738,000 -$297,956 -29% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $815,000 -$292,139 -26% 31 Mar 2020 10-Q 29 Jun 2020 2020 Q1
Q4 2019 $807,000 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $963,434 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,035,956 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $1,107,139 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.